Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

A REVIEW ON: PHARMACOTHERAPY OF HYPERTENSION

  Authors

  Mr. Amol Shinde,  Mrs. Pooja Bhonde,  Dr. Gajanan Sanap,  Mr. Aniket Bankar,  Mr. Sudarshan Chavan

  Keywords

Hypertension, Circadian Rhythm, Pulmonary Arterial Hypertension, Prostanoids, Anticoagulants, etc.

  Abstract


Hypertension will increase with growing age. Optimal remedy of high blood pressure is critical to lessen cardiovascular disease. Recent pointers for high blood pressure have made pointers for older adults however are supported through proof that consists of more youthful individuals. This systematic evaluation evaluates the harms of antihypertensive marketers in adults elderly C65 years. Eligible research covered contributors elderly C65 years with high blood pressure. Eligible research had truly described remedy assignments, blood pressure (BP) targets, and evaluated endpoints of cardiovascular morbidity, mortality, and/or harms of antihypertensive medications. We abstracted take a look at characteristics, cardiovascular blessings, and harms. Most studies as compared distinctive antihypertensive agents and/or placebo groups. These research constantly confirmed decreased cardiovascular morbidity and mortality as compared with out a treatment. Seven research tested optimal BP targets. Strict manipulate [systolic BP (SBP) 140 mmHg] became not constantly higher than mild manipulate (SBP 150 mmHg) for adults aged C65 years. Mild SBP manipulate benefitted topics in all age levels over 65 years. Few research assessed and explicitly reported harms. Hypertensive issues of pregnancy (HDP) constitute a primary purpose of maternal, fetal and neonatal morbidity and mortality and identifies women at risk for cardiovascular and different continual sicknesses later in life. When antihypertensive drugs are used during pregnancy, their benefit and damage to each mother and fetus should be evaluated.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2203355

  Paper ID - 217092

  Page Number(s) - d155-d161

  Pubished in - Volume 10 | Issue 3 | March 2022

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Mr. Amol Shinde,  Mrs. Pooja Bhonde,  Dr. Gajanan Sanap,  Mr. Aniket Bankar,  Mr. Sudarshan Chavan,   "A REVIEW ON: PHARMACOTHERAPY OF HYPERTENSION", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.10, Issue 3, pp.d155-d161, March 2022, Available at :http://www.ijcrt.org/papers/IJCRT2203355.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer